Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth V Schneider

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Structure-kinetic relationship study of CDK8/CycC specific compoundsElisabeth V Schneider, Jark Böttcher, Robert Huber, et al.
Journal of Molecular Biology|February 8, 2024
Cryo-EM Structures of CRAF<sub>2</sub>/14-3-3<sub>2</sub> and CRAF<sub>2</sub>/14-3-3<sub>2</sub>/MEK1<sub>2</sub> ComplexesDirk Dedden, Julius Nitsche, Elisabeth V Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2020
A precisely positioned MED12 activation helix stimulates CDK8 kinase activityFelix Klatt, Alexander Leitner, Iana V Kim, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout CellsMichael F T Koehler, Philippe Bergeron, Elizabeth M Blackwood, et al.
ACS Medicinal Chemistry Letters|June 22, 2016
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8Philippe Bergeron, Michael F T Koehler, Elizabeth M Blackwood, et al.
Nature|September 30, 2015
Mediator kinase inhibition further activates super-enhancer-associated genes in AMLHenry E Pelish, Brian B Liau, Ioana I Nitulescu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Structure-kinetic relationship study of CDK8/CycC specific compoundsElisabeth V Schneider, Jark Böttcher, Robert Huber, et al.
Journal of Molecular Biology|February 8, 2024
Cryo-EM Structures of CRAF<sub>2</sub>/14-3-3<sub>2</sub> and CRAF<sub>2</sub>/14-3-3<sub>2</sub>/MEK1<sub>2</sub> ComplexesDirk Dedden, Julius Nitsche, Elisabeth V Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2020
A precisely positioned MED12 activation helix stimulates CDK8 kinase activityFelix Klatt, Alexander Leitner, Iana V Kim, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout CellsMichael F T Koehler, Philippe Bergeron, Elizabeth M Blackwood, et al.
ACS Medicinal Chemistry Letters|June 22, 2016
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8Philippe Bergeron, Michael F T Koehler, Elizabeth M Blackwood, et al.
Nature|September 30, 2015
Mediator kinase inhibition further activates super-enhancer-associated genes in AMLHenry E Pelish, Brian B Liau, Ioana I Nitulescu, et al.
Pageof 1